Table 3 Incidents during cohort observation period
Recorded Metrics | Patients with histologic remission of EoE on PPI monotherapy and FED monotherapy (n = 9) | Patients with histologic remission of EoE on PPI but not FED monotherapy (n = 6) |
|---|---|---|
 Length of follow up, median yr (IQR) | 2.25 (1.51–2.48) | 1.08 (0.73–2.38) |
 Patients with food impactions requiring urgent EGD, n (%) | 0 (0%) | 0 (0%) |
 Patients with symptom exacerbation requiring urgent follow up visit, n (%) | 0 (0%) | 0 (0%) |
 Pts who underwent repeat EGD while on maintenance treatment plan, n (%) | 1 (11.11%) | 2 (33.33%) |
 Patients with histologic reactivation of EoE while on maintenance treatment plan, n (%) | 0 (0%) | 0 (0%) |
 Patients who underwent repeat EGD to trial other treatment plans, n (%) | 4 (44.44%) | 4 (66.67%) |